Macrophages in Organ Transplantation

Current immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated t...

Full description

Bibliographic Details
Main Authors: Farideh Ordikhani, Venu Pothula, Rodrigo Sanchez-Tarjuelo, Stefan Jordan, Jordi Ochando
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/full
id doaj-974f63c940864aa7b0481d49b70ce256
record_format Article
spelling doaj-974f63c940864aa7b0481d49b70ce2562020-12-08T08:38:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-11-011110.3389/fimmu.2020.582939582939Macrophages in Organ TransplantationFarideh Ordikhani0Venu Pothula1Rodrigo Sanchez-Tarjuelo2Stefan Jordan3Jordi Ochando4Jordi Ochando5Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesImmunología de Trasplantes, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, SpainCurrent immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated that monocytes and macrophages play a pivotal role in graft rejection, as these mononuclear phagocytic cells recognize alloantigens and trigger an inflammatory cascade that activate the adaptive immune response. Moreover, recent studies suggest that monocytes acquire a feature of memory recall response that is associated with a potent immune response. This form of memory is called “trained immunity,” and it is retained by mechanisms of epigenetic and metabolic changes in innate immune cells after exposure to particular ligands, which have a direct impact in allograft rejection. In this review article, we highlight the role of monocytes and macrophages in organ transplantation and summarize therapeutic approaches to promote tolerance through manipulation of monocytes and macrophages. These strategies may open new therapeutic opportunities to increase long-term transplant survival rates in the clinic.https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/fullmacrophagesimmune tolerancetrained immunityorgan transplantationnanotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Farideh Ordikhani
Venu Pothula
Rodrigo Sanchez-Tarjuelo
Stefan Jordan
Jordi Ochando
Jordi Ochando
spellingShingle Farideh Ordikhani
Venu Pothula
Rodrigo Sanchez-Tarjuelo
Stefan Jordan
Jordi Ochando
Jordi Ochando
Macrophages in Organ Transplantation
Frontiers in Immunology
macrophages
immune tolerance
trained immunity
organ transplantation
nanotherapy
author_facet Farideh Ordikhani
Venu Pothula
Rodrigo Sanchez-Tarjuelo
Stefan Jordan
Jordi Ochando
Jordi Ochando
author_sort Farideh Ordikhani
title Macrophages in Organ Transplantation
title_short Macrophages in Organ Transplantation
title_full Macrophages in Organ Transplantation
title_fullStr Macrophages in Organ Transplantation
title_full_unstemmed Macrophages in Organ Transplantation
title_sort macrophages in organ transplantation
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-11-01
description Current immunosuppressive therapy has led to excellent short-term survival rates in organ transplantation. However, long-term graft survival rates are suboptimal, and a vast number of allografts are gradually lost in the clinic. An increasing number of animal and clinical studies have demonstrated that monocytes and macrophages play a pivotal role in graft rejection, as these mononuclear phagocytic cells recognize alloantigens and trigger an inflammatory cascade that activate the adaptive immune response. Moreover, recent studies suggest that monocytes acquire a feature of memory recall response that is associated with a potent immune response. This form of memory is called “trained immunity,” and it is retained by mechanisms of epigenetic and metabolic changes in innate immune cells after exposure to particular ligands, which have a direct impact in allograft rejection. In this review article, we highlight the role of monocytes and macrophages in organ transplantation and summarize therapeutic approaches to promote tolerance through manipulation of monocytes and macrophages. These strategies may open new therapeutic opportunities to increase long-term transplant survival rates in the clinic.
topic macrophages
immune tolerance
trained immunity
organ transplantation
nanotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.582939/full
work_keys_str_mv AT faridehordikhani macrophagesinorgantransplantation
AT venupothula macrophagesinorgantransplantation
AT rodrigosancheztarjuelo macrophagesinorgantransplantation
AT stefanjordan macrophagesinorgantransplantation
AT jordiochando macrophagesinorgantransplantation
AT jordiochando macrophagesinorgantransplantation
_version_ 1724390648396644352